Antje Tunger

1.0k total citations
19 papers, 529 citations indexed

About

Antje Tunger is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Antje Tunger has authored 19 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 11 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Antje Tunger's work include CAR-T cell therapy research (10 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Immunotherapy and Immune Responses (6 papers). Antje Tunger is often cited by papers focused on CAR-T cell therapy research (10 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Immunotherapy and Immune Responses (6 papers). Antje Tunger collaborates with scholars based in Germany, United Kingdom and Italy. Antje Tunger's co-authors include Marc Schmitz, Rebekka Wehner, Luise Müller, Michael Bachmann, Martin Bornhäuser, Ioana Plesca, Manja Wobus, Russell Towers, Malte von Bonin and Francesco Dazzi and has published in prestigious journals such as Nature Communications, International Journal of Cancer and Frontiers in Immunology.

In The Last Decade

Antje Tunger

18 papers receiving 520 citations

Peers

Antje Tunger

ONCOL

IMMUN

GENET

Timothy Krueger United States

Giulia Fregni France

Maria Ravanini Italy

Aslıhan Karabacak Calviello Germany

Gehua Yu China

Dennis F.G. Remst Netherlands

Yanique Rattigan United States

Samantha McGee United States

Nduka Amankulor United States

Jana Muschhammer Germany

Timothy Krueger United States

Antje Tunger

249 ×1.0

ONCOL

190 ×0.8

IMMUN

208 ×1.3

120 ×1.3

GENET

72 ×0.9

Citations per year, relative to Antje Tunger Antje Tunger (= 1×) peers Timothy Krueger

Countries citing papers authored by Antje Tunger

Since Specialization

Citations

This map shows the geographic impact of Antje Tunger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antje Tunger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antje Tunger more than expected).

Fields of papers citing papers by Antje Tunger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antje Tunger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antje Tunger. The network helps show where Antje Tunger may publish in the future.

Co-authorship network of co-authors of Antje Tunger

This figure shows the co-authorship network connecting the top 25 collaborators of Antje Tunger. A scholar is included among the top collaborators of Antje Tunger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antje Tunger. Antje Tunger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Rothe, R, Antje Tunger, Theresa Link, et al.. (2025). Multi-compartment immune cell profiling highlights the prognostic relevance of CD127+ CD8+ T cells for patients with high-grade serous ovarian cancer. Frontiers in Immunology. 16. 1607471–1607471.

Towers, Russell, Antje Tunger, Rebekka Wehner, et al.. (2024). Bone marrow-derived mesenchymal stromal cells obstruct AML-targeting CD8+ clonal effector and CAR T-cell function while promoting a senescence-associated phenotype. Cancer Immunology Immunotherapy. 73(1). 8–8. 12 indexed citations

Schulz, Alexander, Alexander Arthur Wurm, Mildred Sergon, et al.. (2023). BRAF and MEK inhibitor combinations induce potent molecular and immunological effects in NRAS‐mutant melanoma cells: Insights into mode of action and resistance mechanisms. International Journal of Cancer. 154(6). 1057–1072. 5 indexed citations

Arndt, Claudia, Antje Tunger, Rebekka Wehner, et al.. (2023). Palbociclib impairs the proliferative capacity of activated T cells while retaining their cytotoxic efficacy. Frontiers in Pharmacology. 14. 970457–970457. 3 indexed citations

Mentrup, Torben, Christine Schlosser, Katja Schubert, et al.. (2022). Phagosomal signalling of the C-type lectin receptor Dectin-1 is terminated by intramembrane proteolysis. Nature Communications. 13(1). 1880–1880. 25 indexed citations

Wehner, Rebekka, Antje Tunger, Ulrich Julius, et al.. (2022). Repeated lipoprotein apheresis and immune response: Effects on different immune cell populations. Therapeutic Apheresis and Dialysis. 26(S1). 18–28. 1 indexed citations

Müller, Luise, Antje Tunger, Manja Wobus, et al.. (2021). Immunomodulatory Properties of Mesenchymal Stromal Cells: An Update. Frontiers in Cell and Developmental Biology. 9. 637725–637725. 130 indexed citations

Plesca, Ioana, Ulrich Sommer, Rebekka Wehner, et al.. (2021). Tumor-infiltrating plasmacytoid dendritic cells are associated with survival in human colon cancer. Journal for ImmunoTherapy of Cancer. 9(3). e001813–e001813. 91 indexed citations

Plesca, Ioana, Antje Tunger, Luise Müller, et al.. (2020). Characteristics of Tumor-Infiltrating Lymphocytes Prior to and During Immune Checkpoint Inhibitor Therapy. Frontiers in Immunology. 11. 364–364. 51 indexed citations

10.

Müller, Luise, Antje Tunger, Ioana Plesca, et al.. (2020). Bidirectional Crosstalk Between Cancer Stem Cells and Immune Cell Subsets. Frontiers in Immunology. 11. 140–140. 73 indexed citations

11.

Pearson, Frances E., Kirsteen M. Tullett, Ingrid Leal Rojas, et al.. (2020). Human CLEC9A antibodies deliver Wilms' tumor 1 (WT1) antigen to CD141⁺ dendritic cells to activate naïve and memory WT1‐specific CD8⁺ T cells. Clinical & Translational Immunology. 9(6). e1141–e1141. 31 indexed citations

12.

Seifert, Adrian M., Rebekka Wehner, Antje Tunger, et al.. (2020). PD-1 Expression by Lymph Node and Intratumoral Regulatory T Cells Is Associated with Lymph Node Metastasis in Pancreatic Cancer. Cancers. 12(10). 2756–2756. 19 indexed citations

13.

Tunger, Antje, Ulrich Sommer, Rebekka Wehner, et al.. (2019). The Evolving Landscape of Biomarkers for Anti-PD-1 or Anti-PD-L1 Therapy. Journal of Clinical Medicine. 8(10). 1534–1534. 41 indexed citations

14.

Tunger, Antje, Rebekka Wehner, Achim Temme, et al.. (2018). Immune Monitoring of Cancer Patients Prior to and During CTLA-4 or PD-1/PD-L1 Inhibitor Treatment. Biomedicines. 6(1). 26–26. 18 indexed citations

15.

Kubasch, Anne Sophie, Rebekka Wehner, Antje Tunger, et al.. (2018). Clinical, molecular, and immunological responses to pembrolizumab treatment of synchronous melanoma and acute myeloid leukemia. Blood Advances. 2(11). 1187–1190. 5 indexed citations

16.

Tunger, Antje, et al.. (2017). Enumeration of WT1‐specific CD8⁺ T cells for clinical application using an MHC Streptamer based no‐wash single‐platform flow‐cytometric assay. Cytometry Part A. 91(10). 1001–1008. 1 indexed citations

17.

Tunger, Antje, Raphael Teipel, Rebekka Wehner, et al.. (2016). Longitudinal analyses of leukemia-associated antigen-specific CD8+ T cells in patients after allogeneic stem cell transplantation. Experimental Hematology. 44(11). 1024–1033.e1. 4 indexed citations

18.

Wehner, Rebekka, Antje Tunger, Anja Kunze, et al.. (2013). TLR7/8 agonists trigger immunostimulatory properties of human 6-sulfo LacNAc dendritic cells. Cancer Letters. 335(1). 119–127. 13 indexed citations

19.

Buduneli, Eralp, et al.. (2001). Comparative clinical and microbiological effects of subgingival metronidazole application in adult periodontitis; 12-months results.. PubMed. 3(4). 81–6. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact